A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Patients with Primary Knee Osteoarthritis - ENX-CL-05-002
Latest Information Update: 04 May 2026
At a glance
- Drugs Leukocyte-cell-therapy-Enlivex-Therapeutics (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms ENX-CL-05-002
- Sponsors Enlivex Therapeutics
Most Recent Events
- 04 May 2026 New trial record